We are live on ! Find out more
JANX icon

Janux Therapeutics
JANX

49 hedge funds and large institutions have $388M invested in Janux Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 12

22% more capital invested

Capital invested by funds: $318M → $388M (+$70.1M)

11% more funds holding

Funds holding: 44 → 49 (+5)

6.21% more ownership

Funds ownership: 69.45% → 75.66% (+6.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
49
Holders Change
+5
Holders Change %
+11.36%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
18
Reduced
12
Closed
–
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$23.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.63M
3
WP
Woodline Partners
California
+$1.52M
4
Morgan Stanley
Morgan Stanley
New York
+$1.52M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.48M

Top Sellers

1
Cerity Partners
Cerity Partners
New York
-$601K
2
Wells Fargo
Wells Fargo
California
-$395K
3
Bank of America
Bank of America
North Carolina
-$138K
4
N
Nuveen
North Carolina
-$26.7K
5
Goldman Sachs
Goldman Sachs
New York
-$24.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$190K -$24.3K -1,817 -11%
CPIG
27
Chicago Partners Investment Group
Illinois
$181K +$142K +10,621 New
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$180K +$70.1K +5,246 +65%
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
$165K +$163K +12,182 New
MIM
30
MetLife Investment Management
New Jersey
$144K – – –
Deutsche Bank
31
Deutsche Bank
Germany
$110K -$15.3K -1,143 -12%
AIG
32
American International Group
New York
$110K +$1.54K +115 +1%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$103K +$102K +7,638 New
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$92K -$7.54K -564 -8%
O
35
OrbiMed
New York
$38.4K – – –
AB
36
Amalgamated Bank
New York
$30K – – –
Legal & General Group
37
Legal & General Group
United Kingdom
$24K +$4.04K +302 +21%
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$18.7K – – –
TRCT
39
Tower Research Capital (TRC)
New York
$16K -$10.8K -809 -41%
Citigroup
40
Citigroup
New York
$13K -$15.6K -1,166 -54%
AIP
41
Ameritas Investment Partners
Nebraska
$13K – – –
Barclays
42
Barclays
United Kingdom
$10K -$1.76K -132 -15%
CUAMC
43
China Universal Asset Management Company
China
$5K +$5.21K +390 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$3K +$1.83K +137 +141%
CA
45
Crewe Advisors
Utah
$2K – – –
Daiwa Securities Group
46
Daiwa Securities Group
Japan
$2K – – –
Wells Fargo
47
Wells Fargo
California
$1K -$395K -29,595 -100%
CS
48
Credit Suisse
Switzerland
$1K +$1.03K +77 +453%
CAL
49
Capital Advisors Ltd
Ohio
$1K +$1.2K +90 New
1
2

JANX Hedge Fund Activity: Q3 2022 in Review

49 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Janux Therapeutics (JANX) for Q3 2022, worth a combined $388M — up 22% from $318M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new JANX positions and 0 closed out — a net gain of 5 holders — while 18 added to existing stakes and 12 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $23.9M. The largest seller was Cerity Partners, cutting an estimated $601K.

  • 49 institutional investors held Janux Therapeutics (JANX) as of Q3 2022, up from 44 in Q2 2022.
  • Funds reported $388M of Janux Therapeutics stock for Q3 2022, up 22% quarter-over-quarter.
  • 5 funds opened new Janux Therapeutics positions in Q3 2022 and 0 closed out, a net change of +5 holders.
  • The largest Janux Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $23.9M added.
  • The largest Janux Therapeutics seller in Q3 2022 was Cerity Partners, an estimated $601K sold.

Based on aggregated 13F filings for Q3 2022.